These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7972573)

  • 1. Factor structure of the negative symptom assessment.
    Axelrod BN; Goldman RS; Woodard JL; alphs LD
    Psychiatry Res; 1994 May; 52(2):173-9. PubMed ID: 7972573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the 16-item Negative Symptom Assessment.
    Axelrod BN; Goldman RS; Alphs LD
    J Psychiatr Res; 1993; 27(3):253-8. PubMed ID: 7905033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative symptom assessment of chronic schizophrenia patients.
    Raskin A; Pelchat R; Sood R; Alphs LD; Levine J
    Schizophr Bull; 1993; 19(3):627-35. PubMed ID: 8235463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative symptoms in schizophrenia: a confirmatory factor analysis of competing models.
    Peralta V; Cuesta MJ
    Am J Psychiatry; 1995 Oct; 152(10):1450-7. PubMed ID: 7573583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal cutoff scores of the Chinese version of 15-item negative symptom assessment that indicate prominent negative symptoms of schizophrenia.
    Zhou Q; Pu CC; Huang BJ; Miao Q; Zhou TH; Cheng Z; Gao TQ; Shi C; Yu X
    Front Psychiatry; 2023; 14():1154459. PubMed ID: 37139322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A six-factor model of cognition in schizophrenia and related psychotic disorders: relationships with clinical symptoms and functional capacity.
    Gladsjo JA; McAdams LA; Palmer BW; Moore DJ; Jeste DV; Heaton RK
    Schizophr Bull; 2004; 30(4):739-54. PubMed ID: 15957196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor structure and clinical validity of competing models of positive symptoms in schizophrenia.
    Peralta V; Cuesta MJ
    Biol Psychiatry; 1998 Jul; 44(2):107-14. PubMed ID: 9646892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the Spanish version of the Clinical Assessment for Negative Symptoms (CAINS).
    Valiente-Gómez A; Mezquida G; Romaguera A; Vilardebò I; Andrés H; Granados B; Larrubia J; Pomarol-Clotet E; McKenna PJ; Sarró S; Bernardo M
    Schizophr Res; 2015 Aug; 166(1-3):104-9. PubMed ID: 26116328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar and contrasting dimensions of social cognition in schizophrenia and healthy subjects.
    Mehta UM; Thirthalli J; Bhagyavathi HD; Keshav Kumar J; Subbakrishna DK; Gangadhar BN; Eack SM; Keshavan MS
    Schizophr Res; 2014 Aug; 157(1-3):70-7. PubMed ID: 24910445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining the latent structure of negative symptoms: is there a distinct subtype of negative symptom schizophrenia?
    Blanchard JJ; Horan WP; Collins LM
    Schizophr Res; 2005 Sep; 77(2-3):151-65. PubMed ID: 15916881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptom dimensions and cognitive and social functioning in recent-onset schizophrenia.
    Van der Does AJ; Dingemans PM; Linszen DH; Nugter MA; Scholte WF
    Psychol Med; 1993 Aug; 23(3):745-53. PubMed ID: 8234580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empirical validation of primary negative symptoms: independence from effects of medication and psychosis.
    Kelley ME; van Kammen DP; Allen DN
    Am J Psychiatry; 1999 Mar; 156(3):406-11. PubMed ID: 10080556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Social cognition in early course of schizophrenia: Exploratory factor analysis.
    Mike L; Guimond S; Kelly S; Thermenos H; Mesholam-Gately R; Eack S; Keshavan M
    Psychiatry Res; 2019 Feb; 272():737-743. PubMed ID: 30832194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining the reliability and validity of the Clinical Assessment Interview for Negative Symptoms within the Management of Schizophrenia in Clinical Practice (MOSAIC) multisite national study.
    Blanchard JJ; Bradshaw KR; Garcia CP; Nasrallah HA; Harvey PD; Casey D; Csoboth CT; Hudson JI; Julian L; Lentz E; Nuechterlein KH; Perkins DO; Skale TG; Snowden LR; Tandon R; Tek C; Velligan D; Vinogradov S; O'Gorman C
    Schizophr Res; 2017 Jul; 185():137-143. PubMed ID: 28087270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptom structure in schizophrenia: two-, three- or four-factor models?
    Dollfus S; Everitt B
    Psychopathology; 1998; 31(3):120-30. PubMed ID: 9636941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latent trait modelling of symptoms of schizophrenia.
    Bell RC; Low LH; Jackson HJ; Dudgeon PL; Copolov DL; Singh BS
    Psychol Med; 1994 May; 24(2):335-45. PubMed ID: 8084929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cross-national factor analytic comparison of three models of PANSS symptoms in schizophrenia.
    Stefanovics EA; Elkis H; Zhening L; Zhang XY; Rosenheck RA
    Psychiatry Res; 2014 Oct; 219(2):283-9. PubMed ID: 24930581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor structure in the Camberwell Assessment of Need-Patient Version: the correlations with dimensions of illness, personality and quality of life of schizophrenia patients.
    Ritsner MS; Lisker A; Arbitman M; Grinshpoon A
    Psychiatry Clin Neurosci; 2012 Oct; 66(6):499-507. PubMed ID: 23066767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metacognitive deficits predict future levels of negative symptoms in schizophrenia controlling for neurocognition, affect recognition, and self-expectation of goal attainment.
    Lysaker PH; Kukla M; Dubreucq J; Gumley A; McLeod H; Vohs JL; Buck KD; Minor KS; Luther L; Leonhardt BL; Belanger EA; Popolo R; Dimaggio G
    Schizophr Res; 2015 Oct; 168(1-2):267-72. PubMed ID: 26164820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.